Home / Public Antibody Sequence Database / Daratumumab PUBLIC ANTIBODY SEQUENCE · PSC-CD38-005 Daratumumab antibody sequence CD38 · CD38
A high-value reference antibody for multiple-myeloma, plasma-cell phenotyping and CD38 receptor-occupancy research.
CD38 ADPRC1 T10 Whole mAb IgG1
Project planning Technical review required Scope and timing are confirmed only after the sequence, construct, labeling plan and requested deliverables have been assessed.
Ask about expression and labeling VH · Heavy chain variable region 122 aa
EVQLLESGGGLVQPGGSLRLSCAVSGFTFNSFAMSWVRQAPGKGLEWVSAISGSGGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKDKILWFGEPVFDYWGQGTLVTVSSVL · Light chain variable region 107 aa
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPTFGQGTKVEIKRecord information
Antibody name Daratumumab
Target CD38
Gene symbol CD38
Molecular format Whole mAb
Heavy-chain isotype IgG1
Light-chain type Kappa
Project code PSC-CD38-005 Alternate names Darzalex · HuMax-CD38 · JNJ-54767414
RESEARCH USE Suggested research applications Plasma-cell phenotyping CD38 binding detection Receptor-occupancy studies Flow cytometry FLUORESCENT OPTIONS Suggested starting labels UV421 SF488 PE APC
Dye selection can be adjusted for instrument lasers, co-expression intensity and panel design. Final selection is confirmed during project assessment.
DELIVERABLE Optional project scope Sequence review and construct design Recombinant expression and purification Fluorescent conjugation and free-dye removal Concentration, appearance and agreed basic quality checks START FROM THIS SEQUENCE Start a project from this public sequence Submit the intended antibody format, scale, fluorophore and application. We will first confirm the technical route and delivery boundaries.
Use and intellectual-property boundaries A public sequence does not imply freedom to operate or a commercial license. This record supports research search and project discussion. Customers should complete patent, licensing and freedom-to-operate assessment for the intended use. Antibody names and related trademarks belong to their respective owners; this page does not imply affiliation with or authorization from the originator company.